Table 1.
Summary of GWAS datasets used for LPH levels and CRC.
LPH GWAS | CRC GWAS | Colon Cancer GWAS | Rectal Cancer GWAS | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | First Author (Year) | Sample Size | Population | Sex | Study | N Cases | N Controls | Population | Sex | CRC Ascertainment | N Cases | N Controls | N Cases | N Controls |
Fenland Study | Pietzner (2021) [44] | 10,708 | 100% European | 53% Female | FinnGen Study | 6509 | 287,137 | 100% European | 42% Female | ICD10: C18–C20 | 3935 | 287,137 | 2361 | 287,137 |
PLCO Atlas | 2065 | 67,500 | 100% European | 45% Female | ICD-O-2 Site: 180/182–189/199/209/212/218 | 1611 | 65,142 | 320 | 65,142 | |||||
Pan-UK Biobank | 592 | 419,881 | 100% European | 44% Female | Self-reported diagnosis of large bowel cancer/colorectal caner | 1384 | 419,089 | 301 | 420,172 |
Abbreviations: GWAS: genome-wide association studies; LPH: lactase-phlorizin hydrolase; CRC: colorectal cancer.